Elite Pharmaceuticals Inc
ELTP- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001053369
In the last 90 days, Elite Pharmaceuticals Inc insiders filed 2 open-market purchases and 0 sales; 1 institution reported holding it in 13F filings for Q2 2026, worth $365 in total; no superinvestor holds it.
Holders of 5% or more of ELTP
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Elite Pharmaceuticals Inc, largest stake first. The change is against the holder's previous filing.
No holder currently reports owning 5% or more of Elite Pharmaceuticals Inc on Schedule 13D or 13G.
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
Schedule 13D and 13G filings on Elite Pharmaceuticals Inc, newest first.
No Schedule 13D or 13G filings on Elite Pharmaceuticals Inc are on file.
Form 144: proposed insider sales
3 notices from officers, directors and other affiliates planning to sell Elite Pharmaceuticals Inc shares, newest first.
| Filed (ET) | Seller | Shares to sell | Market value | Planned sale | Broker | Filing |
|---|---|---|---|---|---|---|
| Aug 22, 20259:39 AM ET | Plassche DouglasOfficer | 100.0K | $555.0KCheck value | Aug 22, 2025 | Fidelity Brokerage Services LLC | SEC |
| Jul 8, 202510:58 AM ET | Plassche DouglasOfficer | 500.0K | $303.0K | Jul 8, 2025 | Fidelity Brokerage Services LLC | SEC |
| Oct 23, 20248:27 AM ET | Plassche DouglasOfficer | 1.13M | $680.4K | Oct 23, 2024 | Fidelity Brokerage Services LLC | SEC |